Supported by

Stable CAD (Coronary artery disease)

Find all the latest content on stable coronary artery disease (stable CAD) published on this website.

A complex and changing disease state requiring wide expertise, stable CAD can involve a diverse range of underlying chronic or evolutionary stages involving full use of all available tools, devices and techniques like those for invasive imaging and functional assessment. Taking into account underlying comorbidities such as diabetes is critical. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks, all of which can be found here…

Filtered By
Stable CAD

361 results

Percutaneous coronary intervention vs coronary artery bypass graft surgery for left main disease in patients with and without acute coronary syndromes: a pooled analysis of 4 randomized clinical trials

05 Jul 2023

This patient-level analysis of randomized trials comparing PCI vs CABG for the treatment of low-to-intermediate CAD involving the LM confirms the absence of long-term differences in mortality between revascularization techniques, regardless of the clinical presentation.

Giovanni Occhipinti

Reviewer

Giovanni Occhipinti
Daniele Giacoppo

Reviewer

Daniele Giacoppo
PCI vs CABG surgery for LM disease in patients with and without ACS: a pooled analysis of 4 randomized clinical trials

PCI or CABG for left main coronary artery disease: the SWEDEHEART registry

28 Jun 2023

While the choice between PCI and CABG for LMCA disease continues to be one of the most controversial topics, patient characteristics & comorbidities must be taken into account, as must the external validity of the results of RCTs in the real world, as the SWEDEHEART registry does.

Panagiotis Xaplanteris

Reviewer

Panagiotis Xaplanteris

Reviewer

Leonidas Koliastasis
PCI or CABG for left main coronary artery disease: the SWEDEHEART registry

EuroPCR 2023 Highlights: Coronary Interventions

20 May 2023 – From EuroPCR 2023

Nieves Gonzalo and Thomas Cuisset join Dejan Milasinovic in the PCR recording studio to share their takeaways from this rich edition of EuroPCR: intracoronary physiology guidance, post-PCI physiology, the increasing use of imaging to improve the clinical outcome of patients, new technologies such as drug-coated balloons,...

EuroPCR 2023 Highlights: Coronary Interventions

How have REVIVED (percutaneous revascularization for ischemic left ventricular dysfunction) results changed my practice?

17 May 2023 – From EuroPCR 2023

Mirvat Alasnag and Ajay Kirtane reflect on the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunction) randomised trial 9 months after its release. They discuss how the unexpected results had an effect on their practice, and how results compare to those of the STICH trial.

How have REVIVED results changed my practice?

EuroPCR 2023 Hotlines/Late-Breaking Trials: focus on wire and image-based physiology

18 May 2023 – From EuroPCR 2023

Find out more about a series of studies focusing on wire and image based physiology: Coronary microvascular function and CT coronary angiography trial aiming to assess whether endotype diagnosis informed by coronay function testing vs angiography improved angina; a 5-year follow up of the DEFINE FLAIR;...

wire and image-based physiology

Innovations in coronary disease, diagnosis and treatment

18 May 2023 – From EuroPCR 2023

Join the panelists as they present a series of innovations in coronary disease. Amplify your insight into this vital topic and uncover an array of novelties in diagnosis and treatment.

Innovations in coronary disease, diagnosis and treatment

Current indications for DCB in de novo lesions

18 May 2023 – From EuroPCR 2023

If you are interested in learning more about drug-coated balloon angioplasty in de novo disease, don't miss this informative session, which incorporates real-life cases. The session begins with a comprehensive review of the top five papers published in the past year, focusing on this topic. Additionally,...

Current indications for DCB in de novo lesions

Coronary artery disease: more imaging, less imagination

18 May 2023 – From EuroPCR 2023

In these slides, explore associations between angiography-based FFR and OCT-detected luminal obstruction, prognostic impact of ischaemia vs. plaque vulnerability, CT's mortality foresight, and much more.

Coronary artery disease: more imaging, less imagination

Cathlab: different issues

18 May 2023 – From EuroPCR 2023

Discover this series of slides specialised for nurses and allied professionals (NAPs). Explore topics such as the road to and from the cathlab,  contrast-induced nephropathy, cerebral embolic protection during TAVI, educational guides, emerging technologies'  and address radiation concerns for pregnant cathlab staff with best protection practices.

Cathlab: different issues

PCI for complex coronary lesions

18 May 2023 – From EuroPCR 2023

Gain valuable insights into the management of challenging coronary lesions during PCI in this session: witness the effective treatment of in-stent restenosis through the innovative use of intravascular lithotripsy, explore the techniques employed to address non-expandable stents, discover the utility of the Guide Extension catheter system...

PCI for complex coronary lesions